Galderma Group AG (GDERF)
205.25
+9.50
(+4.85%)
USD |
OTCM |
Dec 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 48.20B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 111.9% |
| Valuation | |
| PE Ratio | 129.11 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 10.48 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.0746 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland. |
| URL | http://www.galderma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zug |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 05, 2026 |
| Last Earnings Release | Jul. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 28, 2025 |
Ratings
Profile
| Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland. |
| URL | http://www.galderma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zug |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 05, 2026 |
| Last Earnings Release | Jul. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 28, 2025 |